Evaluation of endometrial histologic morphology in patients with polycystic ovary syndrome

被引:1
|
作者
Rudnicka, Ewa [1 ]
Wierzba, Waldemar [1 ]
Radowicki, Stanislaw [1 ]
机构
[1] Warszawskiego Uniwersytetu Med, Klin Endokrynol Ginekol, PL-00315 Warsaw, Poland
关键词
polycystic ovary syndrome; endometrium; biopsy; androgens; ANDROGEN EXCESS; WOMEN; HYPERPLASIA; PREVALENCE; EXPRESSION;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: To evaluate endometrial histologic morphology in patients with polycystic ovary syndrome. Material and methods: 93 women, aged 78-35, who were hospitalized in the Gynaecologic Endocrinology Department of Warsaw Medical University due to PCOS have been qualified for the research. All patients had menstrual pattern of oligomenorrhoea and mean cycle length of 49 38 days. The control group consisted of 40 healthy women with regular menstrual cycles and no symptoms of hyperandrogenism. In case of each patient the fallowing data were analyzed: age, menarche age, Body Mass Index and endometrium histologic findings. The endometrium was aspirated using the Pipelle probe. Statistic analysis was performed and the values of p<0.05 were deemed statistically significant. Results: No statistical significance was found between the age of the patients, their menarche age and BMI. Proliferative endometrium was significantly more often observed (p<0.01) in patients with PCOS (64.52 %) than in the control group (15%). Secretory endometrium was found in 23.65 % of the examined patients. This result differed statistically from the 85 % rate in the control group (p<0.01). In case of PCOS patients, mixed type endometrium was found in 70 patients (10.75%) and simple endometrial hyperplasia without atypia was found in I patient (1.08%). Conclusions: 1. Lack of ovulation or late ovulation play a crucial role in endometrial cyclic transformation and its disorders. 2. The prolonged endometrial proliferation phase is a characteristic feature of women suffering from PCOS.
引用
收藏
页码:103 / 106
页数:4
相关论文
共 50 条
  • [21] Analysis on Reverse of Atypical Endometrial Hyperplasia by Drugs in Patients with Polycystic Ovary Syndrome
    Xiao-fang LOU
    Jin-fang LIN
    Su-ping FANG
    Feng-ling WANG
    Journal of Reproduction and Contraception, 2013, (04) : 205 - 214
  • [22] Research progress of endometrial receptivity in patients with polycystic ovary syndrome: a systematic review
    Bai, Xuechun
    Zheng, Lianwen
    Li, Dandan
    Xu, Ying
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2021, 19 (01)
  • [23] Research progress of endometrial receptivity in patients with polycystic ovary syndrome: a systematic review
    Xuechun Bai
    Lianwen Zheng
    Dandan Li
    Ying Xu
    Reproductive Biology and Endocrinology, 19
  • [24] Is endometrial receptivity impaired in women with polycystic ovary syndrome?
    Palomba, Stefano
    Falbo, Angela I.
    Marci, Roberto
    Caserta, Donatella
    MINERVA OBSTETRICS AND GYNECOLOGY, 2023, 75 (02) : 172 - 180
  • [25] Evaluation of serum calprotectin levels in patients with polycystic ovary syndrome
    Rıfat Şener
    Süleyman Erkan Alataş
    Ömer Tolga Güler
    Scientific Reports, 15 (1)
  • [26] Evaluation of electrocardiographic repolarization parameters in patients with polycystic ovary syndrome
    Orosz, A.
    Szabo, L. A.
    Vagvolgyi, A.
    Magony, S.
    Nyiraty, S. Z.
    Toth, B.
    Pesei, F.
    Abraham, G. Y.
    Nemes, A.
    Lengyel, C. S.
    Varkonyi, T.
    Baczko, I
    CARDIOVASCULAR RESEARCH, 2022, 118 (SUPPL 1)
  • [27] The evaluation of temperament and quality of life in patients with polycystic ovary syndrome
    Dag, Zeynep Ozcan
    Alpua, Murat
    Isik, Yuksel
    Buturak, S. Visal
    Tulmac, Ozlem B.
    Turkel, Yakup
    GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (03) : 250 - 253
  • [28] Evaluation of Gallbladder Motility in Patients with Polycystic Ovary Syndrome.
    Isik, S.
    Ozcan, H. N.
    Berker, D.
    Tutuncu, Y.
    Ozuguz, U.
    Akbaba, G.
    Guler, S.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [29] Evaluation of oxidative stress and inflammation in patients with polycystic ovary syndrome
    Sen, Berra
    Gonultas, Senem
    Albayrak, Ceren
    Temur, Sevval
    Acar, Ilgar
    Ozkan, Beyza Nur
    Islek, Havva Sevde
    Yilmaz, Muserref Banu
    Kale, Ebru
    Guler, Eray Metin
    OBSTETRICS & GYNECOLOGY SCIENCE, 2024, 67 (04) : 414 - 420
  • [30] Prospective, population-based evaluation of insulin resistance, polycystic ovary syndrome and metabolic syndrome in a cohort of patients with endometrial cancer
    Burzawa, J. K.
    Schmeler, K. M.
    Soliman, P. T.
    Lacour, R. A.
    Meyer, L. A.
    Bevers, M. W.
    Frurnovitz, M. M.
    Pustilnik, T. B.
    Brown, J.
    Anderso, M. L.
    Ramondetta, L. M.
    Tortolero-Luna, G.
    Gershenson, D. M.
    Lu, K. H.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S85 - S85